异动解读 | 业绩超预期并上调全年指引，Doximity盘中大涨9.79%

异动解读

Aug 08

医疗专业人士数字平台Doximity(股票代码:DOCS)周五盘中大涨9.79%，截至发稿报64.28美元。该公司周四晚间发布的强劲财报以及乐观的全年展望推动了股价上涨。

Doximity公布的截至6月30日的季度业绩显示，调整后每股收益达到36美分，远超分析师平均预期的30美分。公司营收同比增长15.2%，达到1.4591亿美元，同样超过了分析师预期的1.3954亿美元。此外，Doximity上调了2026财年销售额预期，从早先预计的6.19亿至6.31亿美元上调至6.28亿至6.36亿美元。

受此利好消息影响，多家华尔街投行上调了Doximity的目标价。其中，Canaccord Genuity将目标价从50美元上调至59美元，摩根大通将目标价从60美元上调至62美元，Leerink Partners则将目标价从73美元上调至79美元。分析师普遍认为，Doximity在医疗数字化领域的领先地位和持续增长潜力值得看好。

值得一提的是，Doximity还宣布以最高6,300万美元的价格收购了墨尔本的Pathway Medical，这是一家人工智能驱动的临床参考初创公司。此举显示出Doximity在技术创新方面的持续投入，有望进一步增强其产品竞争力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1168984268"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168984268\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168984268?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-08-08 22:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168984268","market":"sg","top_or_hot":-1,"title":"异动解读 | 业绩超预期并上调全年指引，Doximity盘中大涨9.79%","media":"异动解读","content":"<p>医疗专业人士数字平台Doximity(股票代码:DOCS)周五盘中大涨9.79%，截至发稿报64.28美元。该公司周四晚间发布的强劲财报以及乐观的全年展望推动了股价上涨。</p>\n\n<p>Doximity公布的截至6月30日的季度业绩显示，调整后每股收益达到36美分，远超分析师平均预期的30美分。公司营收同比增长15.2%，达到1.4591亿美元，同样超过了分析师预期的1.3954亿美元。此外，Doximity上调了2026财年销售额预期，从早先预计的6.19亿至6.31亿美元上调至6.28亿至6.36亿美元。</p>\n\n<p>受此利好消息影响，多家华尔街投行上调了Doximity的目标价。其中，Canaccord Genuity将目标价从50美元上调至59美元，摩根大通将目标价从60美元上调至62美元，Leerink Partners则将目标价从73美元上调至79美元。分析师普遍认为，Doximity在医疗数字化领域的领先地位和持续增长潜力值得看好。</p>\n\n<p>值得一提的是，Doximity还宣布以最高6,300万美元的价格收购了墨尔本的Pathway Medical，这是一家人工智能驱动的临床参考初创公司。此举显示出Doximity在技术创新方面的持续投入，有望进一步增强其产品竞争力。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 业绩超预期并上调全年指引，Doximity盘中大涨9.79%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 业绩超预期并上调全年指引，Doximity盘中大涨9.79%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-08-08 22:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>医疗专业人士数字平台Doximity(股票代码:DOCS)周五盘中大涨9.79%，截至发稿报64.28美元。该公司周四晚间发布的强劲财报以及乐观的全年展望推动了股价上涨。</p>\n\n<p>Doximity公布的截至6月30日的季度业绩显示，调整后每股收益达到36美分，远超分析师平均预期的30美分。公司营收同比增长15.2%，达到1.4591亿美元，同样超过了分析师预期的1.3954亿美元。此外，Doximity上调了2026财年销售额预期，从早先预计的6.19亿至6.31亿美元上调至6.28亿至6.36亿美元。</p>\n\n<p>受此利好消息影响，多家华尔街投行上调了Doximity的目标价。其中，Canaccord Genuity将目标价从50美元上调至59美元，摩根大通将目标价从60美元上调至62美元，Leerink Partners则将目标价从73美元上调至79美元。分析师普遍认为，Doximity在医疗数字化领域的领先地位和持续增长潜力值得看好。</p>\n\n<p>值得一提的是，Doximity还宣布以最高6,300万美元的价格收购了墨尔本的Pathway Medical，这是一家人工智能驱动的临床参考初创公司。此举显示出Doximity在技术创新方面的持续投入，有望进一步增强其产品竞争力。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DOCS","symbol_name":"Doximity, Inc.","start_time":0,"source_url":"","article_id":"1168984268","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168984268","pubTimestamp":1754661617,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"医疗专业人士数字平台Doximity周五盘中大涨9.79%，截至发稿报64.28美元。该公司周四晚间发布的强劲财报以及乐观的全年展望推动了股价上涨。此外，Doximity上调了2026财年销售额预期，从早先预计的6.19亿至6.31亿美元上调至6.28亿至6.36亿美元。受此利好消息影响，多家华尔街投行上调了Doximity的目标价。此举显示出Doximity在技术创新方面的持续投入，有望进一步增强其产品竞争力。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"DOCS":"Doximity, Inc."},"translate_title":"Interpretation of changes | Performance exceeded expectations and raised full-year guidance, Doximity rose 9.79% intraday","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DOCS":1},"content_text":"医疗专业人士数字平台Doximity(股票代码:DOCS)周五盘中大涨9.79%，截至发稿报64.28美元。该公司周四晚间发布的强劲财报以及乐观的全年展望推动了股价上涨。\nDoximity公布的截至6月30日的季度业绩显示，调整后每股收益达到36美分，远超分析师平均预期的30美分。公司营收同比增长15.2%，达到1.4591亿美元，同样超过了分析师预期的1.3954亿美元。此外，Doximity上调了2026财年销售额预期，从早先预计的6.19亿至6.31亿美元上调至6.28亿至6.36亿美元。\n受此利好消息影响，多家华尔街投行上调了Doximity的目标价。其中，Canaccord Genuity将目标价从50美元上调至59美元，摩根大通将目标价从60美元上调至62美元，Leerink Partners则将目标价从73美元上调至79美元。分析师普遍认为，Doximity在医疗数字化领域的领先地位和持续增长潜力值得看好。\n值得一提的是，Doximity还宣布以最高6,300万美元的价格收购了墨尔本的Pathway Medical，这是一家人工智能驱动的临床参考初创公司。此举显示出Doximity在技术创新方面的持续投入，有望进一步增强其产品竞争力。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}